Correlation Between Fastly and Transcode Therapeutics
Can any of the company-specific risk be diversified away by investing in both Fastly and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fastly and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fastly Class A and Transcode Therapeutics, you can compare the effects of market volatilities on Fastly and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fastly with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fastly and Transcode Therapeutics.
Diversification Opportunities for Fastly and Transcode Therapeutics
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Fastly and Transcode is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Fastly Class A and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and Fastly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fastly Class A are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of Fastly i.e., Fastly and Transcode Therapeutics go up and down completely randomly.
Pair Corralation between Fastly and Transcode Therapeutics
Given the investment horizon of 90 days Fastly Class A is expected to generate 1.42 times more return on investment than Transcode Therapeutics. However, Fastly is 1.42 times more volatile than Transcode Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Transcode Therapeutics is currently generating about 0.02 per unit of risk. If you would invest 1,090 in Fastly Class A on November 19, 2025 and sell it today you would earn a total of 652.00 from holding Fastly Class A or generate 59.82% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 98.36% |
| Values | Daily Returns |
Fastly Class A vs. Transcode Therapeutics
Performance |
| Timeline |
| Fastly Class A |
| Transcode Therapeutics |
Fastly and Transcode Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Fastly and Transcode Therapeutics
The main advantage of trading using opposite Fastly and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fastly position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.The idea behind Fastly Class A and Transcode Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Transcode Therapeutics vs. In8bio Inc | Transcode Therapeutics vs. Lyra Therapeutics | Transcode Therapeutics vs. Aptevo Therapeutics | Transcode Therapeutics vs. Galecto |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |